Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Asieris, Atara,Dxcover, Hua, Johnson & Johnson, Meiji Seika, Northsea,Pathai, Pharmaessentia, Pierre Fabre , Priovant, Recovryai, Splisense.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbott, Agios, Ascendis, Biomarin, Innocare, Innovent, Intellia, Merck, Novo Nordisk, Protagonist, Sanofi, Scibase, Takeda, Uniqure.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Asieris, Cstone, Dr. Reddy’s, Optellum, Photocure.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: AS Software, Asieris, Boehringer Ingelheim, Deephealth, Eli Lilly, Ipsen, Moderna, Neurogene, Novartis, Optellum, Photocure, Regeneron, Sanofi, Sentynl, Synergy Spine Solutions, X4.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4Web, Catalyst, Eton, Femasys, GSK, Ionis, Qure.ai, Soligenix, Vera, Viridian.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Carla, Johnson & Johnson, Mevion, Opus, Pfizer, Polaroid, Scopbio, Siren, Vanda, Viatris, Xenocor.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aktis, Alpha Tau, Alzecure, Amphastar, Haemonetics, Immedica, Intrabio, Larimar, Macrogenics, Mirus, Regeneron, Sanofi.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Allurion, Armata, Beren, Allurion, Bracco, Cstone, Dr. Reddy’s, Eli Lilly, Guerbet, J&J, Reunion, Sandoz, Savara, Tessera, Teva, Vanda.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Bio-Thera Solutions, Biogen, Daiichi Sankyo, Deciphera, Eisai, Ono, Peijia Medical, Racthera, Stada Arzneimittel, Sumitomo, Takeda, Telix.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Puretech, Roche.